On this page
Evidence dossier
The report behind the claim
The authors reported attenuation of post-embolization disturbances and activation of collateral circulation. Chemical embolization in anesthetized animals is not a human clot-treatment trial.
Pentadecapeptide BPC 157 as Therapy for Inferior Caval Vein Embolization: Recovery of Sodium Laurate-Post-Embolization Syndrome in Rats.
- Design
- Experimental animal investigation with the intervention and outcomes specified in the indexed abstract.
- Participants or model
- Rats given sodium laurate into the inferior caval vein
- Endpoint
- Early pulmonary, vascular, pressure, thrombosis and organ findings
- Finding on record
- The authors reported attenuation of post-embolization disturbances and activation of collateral circulation.
- Limits of inference
- Chemical embolization in anesthetized animals is not a human clot-treatment trial.
The experiment in view
The study used rats given sodium laurate into the inferior caval vein. Its principal measures were early pulmonary, vascular, pressure, thrombosis and organ findings. The authors reported attenuation of post-embolization disturbances and activation of collateral circulation.
Reading the result closely
The embolizing agent and observation period define the experiment. A claim about ordinary leg swelling or prevention during travel would require a different population and design. The collateral-circulation interpretation should remain distinct from direct evidence that an established clot was safely treated in a patient.
The boundary of the finding
Chemical embolization in anesthetized animals is not a human clot-treatment trial.
Related evidence, kept separate
BPC-157 during severe abdominal pressure in rats examines pressure, circulation, thrombosis and organ injury. Here, the measured endpoint was early pulmonary, vascular, pressure, thrombosis and organ findings. Those outcomes belong to separate experiments; one is not a replication or a human confirmation of the other. Compare that distinction with the What changes when a BPC-157 paper becomes a sales claim? appraisal.
On the record
The documents supporting this report.